Dynamic monitoring of circulating tumor DNA to predict prognosis and efficacy of adjuvant chemotherapy after resection of colorectal liver metastases.

Theranostics · 2021 · PMC8171084 · PMID 34093868

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

Two phase III trials (FFCD trial 9002 and the ENG trial) both showed a nonsignificant trend for improvement in DFS and OS for patients treated with adjuvant chemotherapy 22 , 23 , but both trials close prematurely because of slow accrual.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.